SEARCH

SEARCH BY CITATION

References

  • Boscia F, Furino C, Sbornia L et al. (2004): Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138: 10771079.
  • Boscia F, Parodi MB, Furino C et al. (2006): Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 244: 12241232.
  • Bottoni F, Massacesi A, Cigada M et al. (2005): Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123: 16441650.
  • CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL & Jaffe GJ. (2011): Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364: 18971908.
  • Costagliola C, Romano MR, Dell’Omo R, Cipollone U & Polisena P. (2007): Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 144: 449451.
  • Freund KB, Klais CM, Eandi CM et al. (2006): Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124: 487492.
  • Gass JD, Agarwal A, Lavina AM & Tawansy KA. (2003): Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 23: 741751.
  • Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L & Gabrieli CB. (2009): Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 29: 740749.
  • Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS & Conway BP. (2008): Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 28: 689695.
  • Hemeida TS, Keane PA, Dustin L, Sadda SR & Fawzi AA (2010): Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. Br J Ophthalmol 94: 701705.
  • Joeres S, Heussen FM, Treziak T, Bopp S & Joussen AM. (2007): Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245: 15971602.
  • Johnson TM & Glaser BM. (2006): Focal laser ablation of retinal angiomatous proliferation. Retina 26: 765772.
  • Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L & Ambresin A. (2009): Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol 247: 11651171.
  • Krebs I, Krepler K, Stolba U et al. (2008): Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefes Arch Clin Exp Ophthalmol 246: 237243.
  • Lai TYY, Chan WM, Liu DT & Lam DS. (2007): Ranibizumab for retinal angiomatos proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245: 18771880.
  • Meyerle CB, Freund KB, Iturralde D et al. (2007): Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27: 451457.
  • Monson DM, Smith JR, Klein ML & Wilson DJ. (2008): Clinopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 126: 16641668.
  • Montero JA, Fernandez MI, Gomez-Ulla F & Ruiz-Moreno JM (2009): Efficacy of intravitreal bevacizumab to treat retinal angiomatous proliferation stage II and III. Eur J Ophthalmol 19: 448451.
  • Panagiotidis D, Karagiannis DA & Baltatzis S. (2006): Photodynamic therapy in retinal angiomatous proliferation Stage I. Eur J Ophthalmol 16: 326329.
  • Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J et al. (2007): Retinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapy. Eur J Ophthalmol 17: 979982.
  • Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A & Ladas ID. (2009): Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 29: 536544.
  • Sakimoto S, Gomi F, Sakaguchi H & Tano Y. (2005): Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 139: 917918.
  • Shimada H, Kawamura A, Mori R & Yuzawa M. (2007): Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245: 295300.
  • Shiragami C, Iida T, Nagayama D et al. (2007): Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27: 198203.
  • Silva RM, Faria de Abreu JR, Travassos A & Cunha-Vaz JG. (2004): Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses. Graefes Arch Clin Exp Ophthalmol 242: 368376.
  • Silva RM, Cachulo ML, Figueira J et al. (2007): Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol 245: 11311139.
  • Slakter JS, Yannuzzi LA, Schneider U et al. (2000): Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107: 742753.
  • Spaide RF, Sorenson J & Maranan L. (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularisation. Ophthalmology 110: 15171525.
  • Spaide RF, Sorenson J & Maranan L. (2005): Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112: 301304.
  • Van de Moere A, Kak R, Sandhu SS & Talks SJ. (2007): Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 143: 701704.
  • Viola F, Massacesi A, Orzalesi N, Ratiglia R & Staurenghi G. (2009): Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 29: 732739.
  • Yannuzzi LA, Negrao S, Iida T et al. (2001): Retinal angiomatous proliferation in age-related macular degeneration. Retina 21: 416434.